Atlas Trials

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT01189968 · COMPLETED

Trial details

NCT number
NCT01189968
Sponsor
OncoMed Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2010-09-01
Primary completion
2016-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.